Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
After the recognition of the essential role of the immune system in the progression of type 2 diabetes mellitus, more studies are focused on the effects produced by the abnormal differentiation of components of the immune system. In patients suffering from obesity or T2DM, there were alterations in proliferation of T cells and macrophages, and impairment in function of NK cells and B cells, which represented abnormal innate and adaptive immunity. The abnormality of either innate immunity, adaptive immunity, or both was involved and interacted with each other during the progression of T2DM. Although previous studies have revealed the functional involvement of T cells in T2DM, and the regulation of metabolism by the innate or adaptive immune system during the pathogenesis of T2DM, there has been a lack of literature reviewing the relevant role of adaptive and innate immunity in the progression of T2DM. Here, we will review their relevant roles, aiming to provide new thought for the development of immunotherapy in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625 · cited 4×
“A recent study [21] showed that Th1/Th2 ratio and levels of cytokines (e.g., IL-4, IL-10, IL-13, and IFN-γ) were significantly elevated, whereas nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream targets, which act with antioxidant, detoxification, and maintenance of cellular redox homeostasis and g…”
BackgroundInfluentialAlternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197 · cited 9×
“Th1 and Th17 cells release IFN-γ and IL-17, which stimulate proinflammatory M1macrophage differentiation, whereas Th2 cells and Treg cells promote anti-inflammatory M2macrophage polarization via the production of IL-4, IL-10, or IL-13 [23, 86].”
BackgroundInfluentialInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 2×
“They represent a small subset of T lymphocytes constituting only 5–20% of the CD4+ compartment, suppressing effector T cell responses, limiting inflammation, and preventing autoimmunity [14, 32, 33].”
BackgroundThe biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · cited 2×
“, TNFα, IFN-γ, IL-8, and IL10) and expresses CD56bright CD16dim/negative [75].”
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230 · cited 1×
“Previous literature has shown that the accumulation of these cells induces inflammation and insulin resistance [49].”
BackgroundMacrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · cited 1×
“Loss of peroxisome proliferator-activated receptor-γ (PPARγ) (induced by IL4) expression in macrophages can also result in impaired insulin sensitivity in the liver and muscle [85].”
BackgroundMichalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091 · cited 1×
“CD4+ T cells tend to polarize to Treg cells in vitro when treated with TGF-β, which appears to be dependent upon fatty acid oxidation and cholesterol metabolism rather than glycolysis [34, 35].”
BackgroundEosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis
Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A., & Locksley, R. M. (2011) · Science · doi:10.1126/science.1201475 · Cited by 1,376 · cited 2×
“T2DM patients exhibited significant decrease in the number of neutrophils and eosinophils [17, 91].”
BackgroundNormalization of obesity-associated insulin resistance through immunotherapy
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2001 · Cited by 1,370
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160 · cited 1×
“CD4+ effector T cells can be further subdivided into proinflammatory Th1 and Th17 and anti-inflammatory Th2 and Foxp3+ regulatory T (Treg) cell subtypes based on their functionality and the type of cytokine produced [10].”
BackgroundWiner, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M. G., Alonso, M. N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2353 · Cited by 1,050 · cited 1×
“B cells have been shown to play a central role in the development of insulin resistance [67], through the production of IgG antibodies and the activation of T cells and macrophages [68].”
BackgroundInfections in Patients with Diabetes Mellitus
Joshi, N., Caputo, G. M., Weitekamp, M. R., & Karchmer, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412507 · Cited by 1,043 · cited 1×
“NK cell dysfunction was considered to lead to an increased risk of several infections and several cancer types [73].”
BackgroundDe novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927
Lumeng, C. N., DelProposto, J. B., Westcott, D. J., & Saltiel, A. R. (2008) · Diabetes · doi:10.2337/db08-0872 · Cited by 917
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875 · cited 1×
“IL-6, which was reported to be increased in obese individuals, and promoted the development of insulin resistance and T2DM [87], could be secreted from macrophages and adipocytes in adipose tissue [88].”
BackgroundCD4 + CD25 + Foxp3 + regulatory T cells induce alternative activation of human monocytes/macrophages
Tiemessen, M. M., Jagger, A. L., Evans, H. G., van Herwijnen, M. J. C., John, S., & Taams, L. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706832104 · Cited by 852 · cited 4×
“A recent study [21] showed that Th1/Th2 ratio and levels of cytokines (e.g., IL-4, IL-10, IL-13, and IFN-γ) were significantly elevated, whereas nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream targets, which act with antioxidant, detoxification, and maintenance of cellular redox homeostasis and g…”
BackgroundInfluentialKratz, M., Coats, B. R., Hisert, K. B., Hagman, D., Mutskov, V., Peris, E., Schoenfelt, K. Q., Kuzma, J. N., Larson, I., Billing, P. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.010 · Cited by 815 · cited 1×
“In obese humans, AT macrophages displayed profound proinflammatory (M1) polarization, under the influence of local environmental factors within the adipose tissue, and are thereby thought to be the major source of proinflammatory cytokines and chemokines [83, 84].”
BackgroundMurano, I., Barbatelli, G., Parisani, V., Latini, C., Muzzonigro, G., Castellucci, M., & Cinti, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800019-jlr200 · Cited by 726
Foxp3 in control of the regulatory T cell lineage
Zheng, Y., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1455 · Cited by 701 · cited 1×
“They represent a small subset of T lymphocytes constituting only 5–20% of the CD4+ compartment, suppressing effector T cell responses, limiting inflammation, and preventing autoimmunity [14, 32, 33].”
BackgroundKintscher, U., Hartge, M., Hess, K., Foryst-Ludwig, A., Clemenz, M., Wabitsch, M., Fischer-Posovszky, P., Barth, T. F. E., Dragun, D., Skurk, T., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165100 · Cited by 692 · cited 2×
“The accumulation was supported by type I interferon (IFNI) responses [55].”
BackgroundEpigenetic control of T-helper-cell differentiation
Wilson, C. B., Rowell, E., & Sekimata, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2487 · Cited by 682 · cited 13×
“Although it is generally recognized that the number of highly cytotoxic CD56dim NK cells decreased in obese individuals, the number of low cytotoxic CD56bright NK cells increased, along with the cytokines, including NKG2D and IFN-γ, produced by NK cells [80].”
BackgroundInfluentialREGULATION OF TH2 DIFFERENTIATION AND Il4 LOCUS ACCESSIBILITY
Ansel, K. M., Djuretic, I., Tanasa, B., & Rao, A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115821 · Cited by 645 · cited 4×
“A recent study [21] showed that Th1/Th2 ratio and levels of cytokines (e.g., IL-4, IL-10, IL-13, and IFN-γ) were significantly elevated, whereas nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream targets, which act with antioxidant, detoxification, and maintenance of cellular redox homeostasis and g…”
BackgroundInfluentialGoldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644 · cited 1×
“Nowadays, the pathogenesis of T2DM is considered to be linked to both innate and adaptive immune factors that are recognized as important etiological components in the development of insulin resistance [2].”
BackgroundRausch, M. E., Weisberg, S., Vardhana, P., & Tortoriello, D. V. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803744 · Cited by 585
DeFuria, J., Belkina, A. C., Jagannathan-Bogdan, M., Snyder-Cappione, J., Carr, J. D., Nersesova, Y. R., Markham, D., Strissel, K. J., Watkins, A. A., Zhu, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215840110 · Cited by 521 · cited 11×
“Besides, DeFuria et al. argued that HFD induced a significant increase in the proliferation of B cells in VAT [70].”
BackgroundInfluentialExecutive Summary: Standards of Medical Care in Diabetes—2011
(2011) · Diabetes Care · doi:10.2337/dc11-s004 · Cited by 512
Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A. E., Toxavidis, V., Balk, S. P., O’Shea, D., O’Farrelly, C., & Exley, M. A. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.016 · Cited by 512 · cited 1×
“After weight loss, the abundance of iNKT cells was restored [61], followed by improvement in glucose tolerance and insulin sensitivity.”
BackgroundWhat does it take to make a natural killer?
Colucci, F., Caligiuri, M. A., & Di Santo, J. P. (2003) · Nature Reviews Immunology · doi:10.1038/nri1088 · Cited by 493 · cited 1×
“The activity of NK cells is regulated by activating receptors, including NKp30, NKp44, NKp46, NKG2C, and NKG2D, all of which bind ligands present at the surface of tumor cells or infected cells [74].”
BackgroundAdaptive immunity in obesity and insulin resistance
Sell, H., Habich, C., & Eckel, J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.114 · Cited by 486
An Essential Role of the Transcription Factor GATA-3 for the Function of Regulatory T Cells
Wang, Y., Su, M. A., & Wan, Y. Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.012 · Cited by 461 · cited 1×
“Treg cells suppress the levels of effector T cells by various pathways [36], including the inhibition T cell receptor- (TCR-) induced proliferation and IL-2 transcription of conventional T cells (Tcons) [37], the release of anti-inflammatory cytokines like IL-10 and TGF-β [38], the expression of the coinhibitory molec…”
BackgroundThe role of infiltrating immune cells in dysfunctional adipose tissue
Guzik, T. J., Skiba, D. S., Touyz, R. M., & Harrison, D. G. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx108 · Cited by 445 · cited 1×
“The depletion of NKT cells enhances the presence of M1 macrophages in visceral AT and increases insulin resistance and glucose intolerance [63].”
BackgroundImmunological Goings-on in Visceral Adipose Tissue
Mathis, D. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.008 · Cited by 437
Jagannathan-Bogdan, M., McDonnell, M. E., Shin, H., Rehman, Q., Hasturk, H., Apovian, C. M., & Nikolajczyk, B. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002615 · Cited by 417 · cited 1×
“It has been reported that the percentage of Treg cells was decreased in peripheral blood of T2DM patients, especially in newly diagnosed patients, which culminates in the progress of inflammation and insulin resistance [42, 43].”
BackgroundLynch, L., Michelet, X., Zhang, S., Brennan, P. J., Moseman, A., Lester, C., Besra, G., Vomhof-Dekrey, E. E., Tighe, M., Koay, H.-F., et al. (2015) · Nature Immunology · doi:10.1038/ni.3047 · Cited by 386 · cited 1×
“NKT cells refer to a large fraction of NK marker+ T cells (“NKT”) which recognize the major histocompatibility complex (MHC) class I-like CD1d protein expressed on the surface of antigen-presenting cells and use an identical “invariant” TCRα chain [58, 59].”
BackgroundRegulation of Obesity-Related Insulin Resistance with Gut Anti-inflammatory Agents
Luck, H., Tsai, S., Chung, J., Clemente-Casares, X., Ghazarian, M., Revelo, X. S., Lei, H., Luk, C. T., Shi, S. Y., Surendra, A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.001 · Cited by 368 · cited 1×
“In obese individuals, the levels of IFN-γ produced by CD8+ T cells increased when compared with lean individuals, which might modulate the insulin resistance [56].”
BackgroundMcLaughlin, T., Liu, L.-F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D., Tolentino, L., Choi, O., Zhang, H., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304636 · Cited by 364 · cited 1×
“Furthermore, Th1 cell frequency in SAT also correlated with plasma IL-6 levels [15, 22].”
BackgroundIlan, Y., Maron, R., Tukpah, A.-M., Maioli, T. U., Murugaiyan, G., Yang, K., Wu, H. Y., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908771107 · Cited by 327 · cited 1×
“Similar effects were observed by the induction of TGF-β-dependent CD4+ latency-associated peptide (LAP)-positive Tregs, which decreased the number of CD11b+ F4/80+ macrophages and TNF-α in adipose tissue of leptin-deficient ob/ob mice [96].”
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients
Magalhaes, I., Pingris, K., Poitou, C., Bessoles, S., Venteclef, N., Kiaf, B., Beaudoin, L., Da Silva, J., Allatif, O., Rossjohn, J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78941 · Cited by 316 · cited 1×
“It was reported that there was decreased frequency of iNKT cells in VAT and peripheral blood of obese patients [64].”
BackgroundLee, B.-C., Kim, M.-S., Pae, M., Yamamoto, Y., Eberlé, D., Shimada, T., Kamei, N., Park, H.-S., Sasorith, S., Woo, J. R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.002 · Cited by 303 · cited 2×
“Macrophages in adipose tissue were considered as final effector cells, which regulate adipose tissue inflammation [81].”
BackgroundHarford, K. A., Reynolds, C. M., McGillicuddy, F. C., & Roche, H. M. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000565 · Cited by 299
Executive Summary: Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s004 · Cited by 293 · cited 2×
“[1] American Diabetes Association, “Executive summary: standards of medical care in diabetes—2012,” Diabetes care, vol.”
BackgroundRegulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
Kishore, M., Cheung, K. C. P., Fu, H., Bonacina, F., Wang, G., Coe, D., Ward, E. J., Colamatteo, A., Jangani, M., Baragetti, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.017 · Cited by 276
Self-citationObesity accelerates T cell senescence in murine visceral adipose tissue
Shirakawa, K., Yan, X., Shinmura, K., Endo, J., Kataoka, M., Katsumata, Y., Yamamoto, T., Anzai, A., Isobe, S., Yoshida, N., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88606 · Cited by 271
Verboven, K., Wouters, K., Gaens, K., Hansen, D., Bijnen, M., Wetzels, S., Stehouwer, C. D., Goossens, G. H., Schalkwijk, C. G., Blaak, E. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22962-x · Cited by 240 · cited 2×
“It was reported that the percentage of CD45+ leukocytes increased significantly in obese patients with or without T2DM [11].”
BackgroundRegulatory T cells in autoimmune neuroinflammation
Kleinewietfeld, M., & Hafler, D. A. (2014) · Immunological Reviews · doi:10.1111/imr.12169 · Cited by 230 · cited 6×
“Similar effects were observed by the induction of TGF-β-dependent CD4+ latency-associated peptide (LAP)-positive Tregs, which decreased the number of CD11b+ F4/80+ macrophages and TNF-α in adipose tissue of leptin-deficient ob/ob mice [96].”
BackgroundInfluentialAre Natural Killer Cells Protecting the Metabolically Healthy Obese Patient?
Lynch, L. A., O'Connell, J. M., Kwasnik, A. K., Cawood, T. J., O'Farrelly, C., & O'Shea, D. B. (2009) · Obesity · doi:10.1038/oby.2008.565 · Cited by 228 · cited 1×
“number and/or activation of NK cells in the circulation or adipose tissue compared to control subjects [76–78], while a few other studies observed corresponding decreases or no changes at all [79].”
Gu, J., Ni, X., Pan, X., Lu, H., Lu, Y., Zhao, J., Guo Zheng, S., Hippen, K. L., Wang, X., & Lu, L. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.30 · Cited by 204
T‐cell metabolism governing activation, proliferation and differentiation; a modular view
Dimeloe, S., Burgener, A., Grählert, J., & Hess, C. (2017) · Immunology · doi:10.1111/imm.12655 · Cited by 201 · cited 1×
“They represent a small subset of T lymphocytes constituting only 5–20% of the CD4+ compartment, suppressing effector T cell responses, limiting inflammation, and preventing autoimmunity [14, 32, 33].”
BackgroundJejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling
Monteiro-Sepulveda, M., Touch, S., Mendes-Sá, C., André, S., Poitou, C., Allatif, O., Cotillard, A., Fohrer-Ting, H., Hubert, E.-L., Remark, R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.020 · Cited by 170
Zhang, C., Xiao, C., Wang, P., Xu, W., Zhang, A., Li, Q., & Xu, X. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.02.007 · Cited by 166 · cited 1×
“Consistent with these results, oral anti-CD3 plus glucosylceramide (an NKT cell target antigen) treatment has been shown to induce the production of IL-10 and TGF-β, which were associated with improved levels of glucose while fasting, visceral adipose tissue inflammation, liver enzymes, and hepatic steatosis in ob/ob…”
ResultPathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases
Chehimi, M., Vidal, H., & Eljaafari, A. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6070068 · Cited by 166 · cited 1×
“Furthermore, Th1 cell frequency in SAT also correlated with plasma IL-6 levels [15, 22].”
BackgroundBerrou, J., Fougeray, S., Venot, M., Chardiny, V., Gautier, J., Dulphy, N., Toubert, A., & Péraldi, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062418 · Cited by 166 · cited 2×
“has demonstrated that T2DM patients have a decreased frequency of NKp46- and NKG2D-positive NK cells and defects in NK cell function, which was evident from reduced degranulation [5].”
BackgroundLowe, G., Woodward, M., Hillis, G., Rumley, A., Li, Q., Harrap, S., Marre, M., Hamet, P., Patel, A., Poulter, N., et al. (2014) · Diabetes · doi:10.2337/db12-1625 · Cited by 164
IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease
Srenathan, U., Steel, K. J. A., & Taams, L. S. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.05.001 · Cited by 160 · cited 1×
“It is well established that CD8+ T cells can also synthesize and express the proinflammatory cytokine IL-17, which is present in inflammatory tissues in various human inflammatory diseases [48].”
BackgroundInsulin Inhibits IL-10–Mediated Regulatory T Cell Function: Implications for Obesity
Han, J. M., Patterson, S. J., Speck, M., Ehses, J. A., & Levings, M. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302181 · Cited by 156
Qiao, Y.-C., Shen, J. X., He, L., Hong, X., Tian, F., Pan, Y.-H., Liang, L., Zhang, X., & Zhao, H. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3694957 · Cited by 147 · cited 1×
“In obese patients also suffering from T2DM, an even lower percentage of Treg cells was revealed [46].”
BackgroundAlteration of Natural Killer cell phenotype and function in obese individuals
Viel, S., Besson, L., Charrier, E., Marçais, A., Disse, E., Bienvenu, J., Walzer, T., & Dumontet, C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.01.007 · Cited by 135
Procaccini, C., De Rosa, V., Galgani, M., Carbone, F., Cassano, S., Greco, D., Qian, K., Auvinen, P., Calì, G., Stallone, G., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200935 · Cited by 133
Ip, B., Cilfone, N. A., Belkina, A. C., DeFuria, J., Jagannathan‐Bogdan, M., Zhu, M., Kuchibhatla, R., McDonnell, M. E., Xiao, Q., Kepler, T. B., et al. (2016) · Obesity · doi:10.1002/oby.21243 · Cited by 127 · cited 2×
“In addition, the cytokines produced by Th1, IL-2, and TNF-β; the cytokines produced by Th17, IL-17F, and IL-17A; and the cytokines produced by both Th1 and Th17 cells are important for explaining the HbA1c variance [28].”
BackgroundDu, X., Liu, M., Su, J., Zhang, P., Tang, F., Ye, P., Devenport, M., Wang, X., Zhang, Y., Liu, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0012-z · Cited by 123 · cited 3×
“CD39hi Treg cells express higher CTLA-4 and produce more IL-10 than CD39low Tregs [19, 45, 47].”
BackgroundBułdak, Ł., Łabuzek, K., Bułdak, R. J., Kozłowski, M., Machnik, G., Liber, S., Suchy, D., Duława, A., & Okopień, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.11.008 · Cited by 120 · cited 1×
“Metformin could influence macrophages as well by inducing the expression of reactive oxygen species in macrophages, which led to a phenotypic shift in macrophages toward M2-like macrophages via a partially adenosine monophosphate-activated protein kinase(AMPK-) independent manner [94].”
BackgroundSireesh, D., Dhamodharan, U., Ezhilarasi, K., Vijay, V., & Ramkumar, K. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-22913-6 · Cited by 119 · cited 2×
“A recent study [21] showed that Th1/Th2 ratio and levels of cytokines (e.”
BackgroundT Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes
Touch, S., Clément, K., & André, S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0900-5 · Cited by 115 · cited 1×
“Three subgroups of NKT cells can be distinguished according to their antigen specificity and TCR: invariant NKT (iNKT), type II NKT, and NKT-like lymphocytes [60].”
BackgroundDNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human
Simar, D., Versteyhe, S., Donkin, I., Liu, J., Hesson, L., Nylander, V., Fossum, A., & Barrès, R. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.014 · Cited by 113 · cited 1×
“In patients with obesity or T2DM, DNA methylation, which is likely to be an important mechanism contributing to the interindividual variation in function of immune cells, was proved to stimulate the proliferation of B cells [71].”
Backgroundvan Beek, L., Lips, M. A., Visser, A., Pijl, H., Ioan‐Facsinay, A., Toes, R. E. M., Berends, F. J., van Dijk, K. W., Koning, F., & van Harmelen, V. (2013) · Metabolism · doi:10.1016/j.metabol.2013.12.002 · Cited by 101 · cited 1×
“showed that the expression of activation marker CD38 of B cells was significantly higher on circulating B cells in the obese patients with normal glucose tolerance as compared to obese patients suffering from T2DM [69].”
ResultActivated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies
Stentz, F. B., & Kitabchi, A. E. (2003) · Current Drug Targets · doi:10.2174/1389450033490966 · Cited by 99 · cited 1×
“It indicated that T2DM was associated with overactivated T cells and the activation of the inflammatory pathways [8].”
BackgroundImpaired natural killer cell subset phenotypes in human obesity
Bähr, I., Jahn, J., Zipprich, A., Pahlow, I., Spielmann, J., & Kielstein, H. (2018) · Immunologic Research · doi:10.1007/s12026-018-8989-4 · Cited by 92 · cited 1×
“Although it is generally recognized that the number of highly cytotoxic CD56dim NK cells decreased in obese individuals, the number of low cytotoxic CD56bright NK cells increased, along with the cytokines, including NKG2D and IFN-γ, produced by NK cells [80].”
BackgroundMenart, B., RUTTER, R. R., Nowotny, B., Rosenbauer, J., Koliaki, C. C., KAHL, S., Simon, M., Szendroedi, J., Schloot, N. C., Roden, M., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0316 · Cited by 91 · cited 1×
“Despite the several studies analyzing the frequency of iNKT cells in T2DM patients, no specific conclusion has been drawn yet [50, 65].”
BackgroundGut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation
Pindjakova, J., Sartini, C., Lo Re, O., Rappa, F., Coupe, B., Lelouvier, B., Pazienza, V., & Vinciguerra, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01157 · Cited by 81
Zhang, Q., Fang, W., Ma, L., Wang, Z.-D., Yang, Y., & Lu, Y.-Q. (2018) · Medicine · doi:10.1097/md.0000000000010415 · Cited by 77 · cited 2×
“[30] discovered that levels of vascular endothelial growth factor (VEGF), which is related to the progression of diabetic microvascular disease, were positively correlated with Th1 percentage and the ratio of Th1/Th2.”
BackgroundAdipose tissue inflammation: Feeding the development of type 2 diabetes mellitus
Richardson, V. R., Smith, K. A., & Carter, A. M. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.05.002 · Cited by 73 · cited 2×
“Obesity is associated with low-grade inflammation and is responsible for the activation of immune system in patients suffering from T2DM [3].”
BackgroundAdipose tissue NK cells manifest an activated phenotype in human obesity
O’Rourke, R. W., Gaston, G. D., Meyer, K. A., White, A. E., & Marks, D. L. (2013) · Metabolism · doi:10.1016/j.metabol.2013.07.011 · Cited by 72
Regulatory Role of Natural Killer T Cells in Diabetes
Tard, C., Rouxel, O., & Lehuen, A. (2015) · Biomedical Journal · doi:10.1016/j.bj.2015.04.001 · Cited by 65 · cited 1×
“NKT cells refer to a large fraction of NK marker+ T cells (“NKT”) which recognize the major histocompatibility complex (MHC) class I-like CD1d protein expressed on the surface of antigen-presenting cells and use an identical “invariant” TCRα chain [58, 59].”
BackgroundModulation of immune cells and Th1/Th2 cytokines in insulin-treated type 2 diabetes mellitus
Nekoua, M. P., Fachinan, R., Atchamou, A. K., Nouatin, O. P., Amoussou-Guénou, D., Amoussou-Guenou, M., Moutairou, K. A., & Yessoufou, A. (2016) · African Health Sciences · doi:10.4314/ahs.v16i3.11 · Cited by 65 · cited 1×
“T2DM patients exhibited significant decrease in the number of neutrophils and eosinophils [17, 91].”
BackgroundYuan, N., Zhang, H., Qi, W., Wang, P., & Guo, W. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-113454 · Cited by 59 · cited 1×
“It has been reported that the percentage of Treg cells was decreased in peripheral blood of T2DM patients, especially in newly diagnosed patients, which culminates in the progress of inflammation and insulin resistance [42, 43].”
BackgroundKim, Y., Bayona, P. W., Kim, M., Chang, J., Hong, S., Park, Y., Budiman, A., Kim, Y. J., Choi, C. Y., Kim, W. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00696 · Cited by 56 · cited 1×
“Moreover, lamin A/C expression is specifically upregulated in adipose tissue macrophages (ATMs), particularly in CD11c+ M1 ATMs, due to obesity, which could further promote expression of proinflammatory cytokines by enhancing activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NK-κB) [89].”
BackgroundiNKT and MAIT Cell Alterations in Diabetes
Magalhaes, I., Kiaf, B., & Lehuen, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00341 · Cited by 56 · cited 1×
“While recent studies identified that the gut microbiota may play a crucial role in iNKT cell development, it can be speculated that T2D alterations of the gut microbiota, and possibly even AT-associated microbiota, affect iNKT cell homeostasis in the gut and AT [66].”
ResultImpaired Treg and NK cells profile in overweight women with gestational diabetes mellitus
Lobo, T. F., Borges, C. D. M., Mattar, R., Gomes, C. P., Angelo, A. G. S., Pendeloski, K. P. T., & Daher, S. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.12810 · Cited by 54
Lee, C., & Lam, K. S. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12918 · Cited by 52 · cited 1×
“It has also been recognized that insulin resistance during obesity is closely related to adipose tissue inflammation [4].”
BackgroundRegulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
Kishore, M., Cheung, K. C.-P., Fu, H., Bonacina, F., Wang, G., Coe, D., Ward, E. J., Colamatteo, A., Jangani, M., Baragetti, A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.034 · Cited by 52 · cited 1×
“Treg cells suppress the levels of effector T cells by various pathways [36], including the inhibition T cell receptor- (TCR-) induced proliferation and IL-2 transcription of conventional T cells (Tcons) [37], the release of anti-inflammatory cytokines like IL-10 and TGF-β [38], the expression of the coinhibitory molec…”
BackgroundSelf-citationGuo, H., Xu, B., Gao, L., Sun, X., Qu, X., Li, X., Liu, S., Feng, J., Wang, J., Tang, Y., et al. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011272 · Cited by 44
Cortez-Espinosa, N., Cortés-García, J. D., Martínez-Leija, M. E., Rodríguez-Rivera, J. G., Barajas‐López, C., González‐Amaro, R., & Portales‐Pérez, D. P. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.007 · Cited by 42 · cited 2×
“CD39 Treg cells express higher CTLA-4 and produce more IL-10 than CD39 Tregs [19, 45, 47].”
BackgroundZhang, H., Xue, R., Zhu, S., Fu, S., Chen, Z., Zhou, R., Zhigang, T., & Bai, L. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.11 · Cited by 40 · cited 1×
“The expression of CD1d in M2 macrophages could activate NKT cellmediated immune responses and disrupts the immune balance [62].”
BackgroundChen, H., Ren, X., Liao, N., & Wen, F. (2016) · Journal of International Medical Research · doi:10.1177/0300060516672369 · Cited by 40 · cited 1×
“During the progression of T2DM, levels of mRNA and protein of IL-2 and TNF-α in diabetic retinopathy (DR) patients were dramatically higher compared with those of the healthy control group [29].”
ResultCytokine profile and lymphocyte subsets in type 2 diabetes
Francisco, C. D. O., Catai, A. M., Moura-Tonello, S. C. G., Arruda, L. C. M., Lopes, S. L. B., Benze, B. G., Vale, A. M. D., Malmegrim, K. C. R., & Leal, A. M. O. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20155062 · Cited by 35 · cited 5×
“Not only obese T2DM patients but also nonobese T2DM patients exhibited significantly high levels of fecal IgG, which is produced by B cells, compared to control individuals with similar BMI [70, 72].”
BackgroundInfluentialKawarabayashi, R., Motoyama, K., Nakamura, M., Yamazaki, Y., Morioka, T., Mori, K., Fukumoto, S., Imanishi, Y., Shioi, A., Shoji, T., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6549242 · Cited by 34 · cited 1×
“Monocyte surface CD163 expression levels were significantly associated with insulin resistance in type 2 diabetes patients, which showed the pathophysiological role of monocyte CD163 in the development of insulin resistance [90].”
BackgroundOX40 promotes obesity-induced adipose inflammation and insulin resistance
Liu, B., Yu, H., Sun, G., Sun, X., Jin, H., Zhang, C., Shi, W., Tian, D., Liu, K., Xu, H., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2552-7 · Cited by 32 · cited 2×
“OX40 deficiency suppresses CD41+ T cell activation and prevents macrophage infiltration in the adipose tissues of obese mice [97].”
BackgroundMiya, A., Nakamura, A., Miyoshi, H., Takano, Y., Sunagoya, K., Hayasaka, K., Shimizu, C., Terauchi, Y., & Atsumi, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00081 · Cited by 32 · cited 1×
“Patients with T2DM or mice with high-fat diet (HFD) seem to have higher percentage of CD8+ cytokine T cells [49–53]; however, the proportion of CD8+ T cells decreased after 120min of glucose loading [54].”
BackgroundDiet-Induced Obesity Does Not Impact the Generation and Maintenance of Primary Memory CD8 T Cells
Khan, S. H., Hemann, E. A., Legge, K. L., Norian, L. A., & Badovinac, V. P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401685 · Cited by 29 · cited 1×
“Diet-induced obesity did not affect the maintenance of preexisting memory CD8+ T cells, including acquisition of a long-term memory phenotype and function [57].”
Background[Mechanisms of suppression of regulatory T-cells (Treg)].
Flores, J. M. G., & Portales‐Pérez, D. P. (2013) · PubMed · Cited by 27
Zeng, L., Lu, H., Deng, H., Mu, P., Li, X., & Wang, M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0123 · Cited by 27 · cited 1×
“It was reported that both Treg/Th17 ratio and Treg/Th1 ratio decreased in patients suffering from T2DM [44].”
BackgroundTh1/Th2 cytokine expression in diabetic retinopathy
Cao, Y. L., Zhang, F., & Hao, F. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15037311 · Cited by 25 · cited 2×
“B cells support Th17 inflammation in T2DM patients but not in the normal people, whereas monocytes support Th17 inflammation regardless of whether an individual is suffering from T2DM [27].”
BackgroundZhou, J., Wang, Y., He, Y., Gao, Y., Wan, R., Cai, M., Li, W., Chen, R., Walker, E., Zhai, X., et al. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.03.008 · Cited by 20 · cited 4×
“With respect to the relationship between frequency of lymphocytes and activation of disease, it was found that the frequency of IFN-γ-producing CD3+ T cells was positively correlated with body mass index (BMI) [26].”
BackgroundInfluentialControl of T cell effector functions by miRNAs
Inácio, D., Amado, T., Silva‐Santos, B., & Gomes, A. Q. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.011 · Cited by 19 · cited 1×
“influences the production of distinct sets of effector cytokines [9].”
BackgroundErratum: De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2015) · Nature Medicine · doi:10.1038/nm0415-414d · Cited by 19
Xu, X., Lin, S., Chen, Y., Li, X., Ma, S., Fu, Y., Wei, C., Wang, C., & Xu, W. (2017) · PubMed · Cited by 13
Wang, K., Jin, F., Zhang, Z., & Sun, X. (2016) · Medical Science Monitor · doi:10.12659/msm.900842 · Cited by 11
Cited by
Patrinely, J. R., Young, A. C., Quach, H., Williams, G. R., Ye, F., Fan, R., Horn, L., Beckermann, K. E., Gillaspie, E. A., Sosman, J. A., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.05.005 · Cited by 61
“In addition, emerging data have implicated immune activation in a variety of other processes including atherosclerosis, hypertension, diabetes and depression, and it remains unclear how the PD-1/PD-L1 blockade affects these immune-related processes [11-14].”
Background
Metadata
- Authors
- Zhou, T., Hu, Z., Yang, S., Sun, L., Yu, Z., & Wang, G.
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2018-11-08
- Volume
- 2018
- Pages
- 1-9
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- OpenAlex
- W2899748139
- Cited by
- 229
- References
- 101
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.